Submission Deadline: 1 March 2025 (Status: Open)
Special Issue Editor(s)
Dr. Yamixa Delgado
Email
|
Website
San Juan Bautista School of Medicine, Caguas, Puerto Rico
Interests:
cancer therapeutics; chemoresistance; immunotherapeutics; metastasis; drug delivery systems; natural products; epilepsy therapy; epileptogenesis; inflammation; plasticity
Special Issue Information
Dear Colleagues,
Despite the significant advances in cancer treatment attained in recent years, challenges such as drug resistance and adverse side effects continue to plague the therapeutic efforts. Nevertheless, the incorporation of immunomodulators stands out to be a promising strategy for enhancing the efficacy and safety of conventional cancer treatments. The objective of this special issue is to explore the potential of immunomodulators as adjuvant therapies to improve cancer outcomes.
This special issue welcomes submissions that examine the mechanisms influencing immunological pathways and enhancing anti-tumor immunity. Additionally, we invite contributions that examine the potential of immunomodulatory compounds that act synergistically with standard cancer therapies. Topics of interest include, but are not limited to, the identification of novel immunomodulators, their effects on immune cells and immune-related mechanisms (e.g., inflammatory markers), and translational studies evaluating their therapeutic potential. By convening leading experts in this field, this special issue is primed to advance our understanding of how to effectively enhance immune response by incorporating immunomodulators into standard cancer treatment regimens.
Dr. Yamixa Delgado
Guest Editor
Keywords
immunomodulators; cancer; immune response; adjuvant therapies; anti-tumor immunity; immunotherapeutics
Manuscript Submission Information
Manuscripts should be submitted via our online editorial system at https://www.discovmed.com/Journalx_dm/authorLogOn.action by registering and logging in to this website. Once you are registered, click here to start your submission. Manuscripts can be submitted now or up until the deadline. All papers will go through peer-review process. Accepted papers will be published in the journal (as soon as accepted) and meanwhile listed together on the special issue website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts will be thoroughly refereed through a double-blind peer-review process. Please visit the Instruction for Authors page before submitting a manuscript. Submitted manuscripts should be well formatted in good English.
